More importantly, Ma et al. illustrated that USP22 contributed to declined LVEF% and LVFS%, limited myocardial infarction area, alleviated pathological outcomes, and subdued release of CK-MB and LDH, which is again in accordance with our results [10]. The gene discussed is USP22; the disease is myocardial infarction.